PCR-based moleculardiagnostic products
EntroGen is a Los Angeles-based biotechnology company with a primary focus on molecular diagnostics in the areas of hematology and oncology. EntroGen has a growing commercial portfolio of real-time PCR-based tests, with many of its products being used to guide and monitor targeted therapies for various malignancies. Through a network of distributors, EntroGen’s footprint reaches every corner of the globe to deliver reliable and innovative tools to researchers and clinicians.
NEW: Colorectal Cancer Mutation Detection Panel detects 42 total mutations in KRAS, NRAS, BRAF, PIK3CA and AKT1 using 6 reactions per sample!
Sacace Biotechnologies incorporates all functions required – research & development, manufacturing, logistics, marketing and sales of an extensive line of molecular biology diagnostic tests that accurately screen for the presence of disease in human, animal and food. The kits produced by Sacace include all reagents for nucleic acid extraction, reverse transcription, amplification of specific genomic regions and detection by agarose gel electrophoresis or real-time PCR. The products are designed to provide ease-of-use, they are CE marked in compliance with Directive 98/79EC and incorporate the highest quality reagents to ensure consistency, reliability and long shelf life.